Sign up for free insights newsletter
GL

Glanbia plc

GLBLondon Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

€17.05
-3.67%
End of day
Market Cap

$4.24B

P/E Ratio

0.43

Employees

4,963

Dividend Yield

2.52%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.433.471.221.370.261.19
Calmar-1.8215.883.692.740.183.86
Sharpe-0.282.180.820.870.180.76
Omega0.961.371.181.201.081.17
Martin-2.7133.897.928.610.469.12
Ulcer3.733.565.606.3819.548.96

Glanbia plc (GLB) Price Performance

Glanbia plc (GLB) trades on London Stock Exchange in EUR. The company is classified in the Consumer Defensive sector under the Packaged Foods industry. The stock currently trades at EUR17.05, down 3.67% from the previous close.

Over the past year, GLB has traded between a low of EUR8.99 and a high of EUR18.00. The stock has gained 70.9% over this period. It is currently 5.3% below its 52-week high.

Glanbia plc has a market capitalization of $4.24B, with a price-to-earnings ratio of 0.43 and a dividend yield of 2.52%.

About Glanbia plc

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Company Info

Exchange
London Stock Exchange
Currency
EUR

Financial Metrics

Revenue (TTM)
$3.95B
EBITDA
$452.00M
Profit Margin
4.65%
EPS (TTM)
0.41
Book Value
6.93

Technical Indicators

52 Week High
€18.00
52 Week Low
€8.99
50 Day MA
€16.42
200 Day MA
€14.50
Beta
0.47

Valuation

Trailing P/E
0.43
Forward P/E
12.99
Price/Sales
1.07
Price/Book
2.38
Enterprise Value
$4.93B